Sickle cell disease encompasses a wide range of genotypic presentation with particular clinical features. The entity affects millions of people, particularly those whose ancestors came from sub-Saharan Africa and other countries in the Western Hemisphere, Saudi Arabia, and India. Currently, the high frequency of S and C genes reflects natural selection through the protection of heterozygotes against severe malaria, the high frequency of consanguineous marriages, improvement of some public health policies and the nutritional standards in the poorer countries where newborns are now living long enough to present for diagnosis and management. Although there is a high burden of the disease, in many countries, the new-born sickle cell screening test is being performed and is rendering an early diagnosis; however, it is still difficult for sickle cell patients to find proper treatment and adequate follow-up. Moreover, in many countries, patients are neither aware of their diagnosis nor the care they should receive to prevent complications; also, they do not receive adequate genetic counseling. Hemoglobin SC (HbSC) disease is the most frequent double sickle cell heterozygosis found in Brazil. The clinical course tends to be more benign with fewer hospitalizations compared with double homozygotic SS patients. However, HbSC patients may present severe complications with a fatal outcome. We report the case of a 36-year-old man who presented to the emergency care facility with symptoms consistent with the diagnosis of sickling crisis. The outcome was unfavorable and death occurred just hours after admission. The autopsy revealed a generalized vaso-occlusive crisis by sickled red cells, bone marrow necrosis, and fat embolism syndrome.
Keywords
Hemoglobin SC Disease, Bone Marrow, Necrosis, Embolism
References
PereiraSA, BrenerS, CardosoCS, ProiettiAB. Sickle cell disease: quality of life in patients with hemoglobin SS and SC disorders. Rev Bras Hematol Hemoter. 2013;35(5):325-31. [PMID:24255615] [https://doi.org/10.5581/1516-8484.20130110].
Brasil. Ministério da Saúde. Agência Nacional de Vigilância Sanitária. Manual de diagnóstico e tratamento de doenças falciformes. Brasilia: ANVISA; 2001. 10 p.
World Health Organization (WHO). The health of the people: what works. The African Regional Health Report. Africa: WHO; 2014.
GrosseSD, OdameI, AtrashHK, AmendahDD, PielFB, WilliamsTN. Sickle cell disease in Africa: a neglected cause of early childhood mortality. Am J Prev Med. 2011;41(6, Suppl 4):S398-405. [PMID:22099364] [https://doi.org/10.1016/j.amepre.2011.09.013].
ZagoMA, FalcãoRP, PaquiniR. Hematologia: fundamentos e práticas. São Paulo: Atheneu; 2004. p. 295-297.
CamposFPF, FerreiraCR, Felipe-SilvaA. Bone marrow necrosis and fat embolism: an autopsy report of a severe complication of hemoglobin SC disease. Autops Case Rep. 2014;4(2):9-20. [PMID:28580322] [https://doi.org/10.4322/acr.2014.012].
AleluiaMM, FonsecaTCC, SouzaRQ, et al. Comparative study of sickle cell anemia and hemoglobin SC disease: clinical characterization, laboratory biomarkers and genetic profiles. BMC Hematol. 2017;17(1):15. [PMID:28932402] [https://doi.org/10.1186/s12878-017-0087-7].
TsaiIT, HsuCJ, ChenYH, FongYC, HsuHC, TsaiCH. Fat embolism syndrome in long bone fracture—clinical experience in a tertiary referral center in Taiwan. J Chin Med Assoc. 2010;73(8):407-10. [PMID:20728851] [https://doi.org/10.1016/S1726-4901(10)70088-5].
WadeLJ, StevensonLD. Necrosis of the bone marrow with fat embolism in sickle cell anemia. Am J Pathol. 1941;17(1):47-54, 5. [PMID:19970543]
DangNC, JohnsonC, Eslami-FarsaniM, HaywoodLJ. Bone marrow embolism in sickle cell disease: a review. Am J Hematol. 2005;79(1):61-7. [PMID:15849760] [https://doi.org/10.1002/ajh.20348].
TsitsikasDA, GallinellaG, PatelS, SeligmanH, GreavesP, AmosRJ. Bone marrow necrosis and fat embolism syndrome in sickle cell disease: increased susceptibility of patients with non-SS genotypes and a possible association with humen parvovirus B19 infection. Blood Rev. 2014;28(1):23-30. [PMID:24468004] [https://doi.org/10.1016/j.blre.2013.12.002].
RappaportH, RaumM, HorrellJB. Bone marrow embolism. Am J Pathol. 1951;27(3):407-33. [PMID:19970979]
PellAC, ChristieJ, KeatingJF, SutherlandGR. The detection of fat embolism by transesophageal echocardiography during reamed intramedullary nailing: a study of 24 patients with femoral and tibial fractures. J Bone Joint Surg Br. 1993;75(6):921-5. [PMID:8245083]
GurdAR. Fat embolism: an aid to diagnosis. J Bone Joint Surg. 1970;52(4):732-7. [PMID:5487573]
LindequeB, SchoemanH, DommisseG, BoeyensMC, VlokAL. Fat embolism and the fat embolism syndrome: a double-blind therapeutic study. J Bone Joint Surg. 1987;69(1):128-31. [PMID:3818718]
KingMB, HarmonKR. Unusual forms of pulmonary embolism. Clin Chest Med. 1994;15(3):561-80. [PMID:7982347]
BenoitPR, HampsonLG, BurgessJH. Respiratory gas exchange following fractures: the role of fat embolism as a cause of arterial hypoxemia. Surg Forum. 1969;20:214-6. [PMID:5383056]
ChastreJ, FagonJY, SolerP, et al. Bronchoalveolar lavage for rapid diagnosis of the fat embolism syndrome in trauma patients. Ann Intern Med. 1990;113(8):583-8. [PMID:2400168] [https://doi.org/10.7326/0003-4819-113-8-583].
GodeauB, SchaefferA, BachirD, et al. Bronchoalveolar lavage in adult sickle cell patients with acute chest syndrome: value for diagnostic assessment of fat embolism. Am J Respir Crit Care Med. 1996;153(5):1691-6. [PMID:8630622] [https://doi.org/10.1164/ajrccm.153.5.8630622].
StanleyJD, HansonRR, HicklinGA, GlazierAJJr, ErvanianA, JadaliM. Specificity of bronchoalveolar lavage for the diagnosis of fat embolism syndrome. Am Surg. 1994;60(7):537-41. [PMID:7516631]
MimozO, EdouardA, BeydonL, et al. Contribution of bronchoalveolar lavage to the diagnosis of posttraumatic pulmonary fat embolism. Intensive Care Med. 1995;21(12):973-80. [PMID:8750121] [https://doi.org/10.1007/BF01700658].
BallasSK, LieffS, BenjaminLJ, et al. Definitions of the phenotypic manifestations of sickle cell disease. Am J Hematol. 2010;85(1):6-13. [PMID:19902523]